| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/05/2008 | WO2008066558A2 Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines |
| 06/05/2008 | WO2008065490A2 Process for the preparation of atazanavir |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132570 Levodopa prodrugs, and compositions and uses thereof |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | US20080132546 e.g. Methyl 2-(6-{[(ethylamino)carbonyl]amino}pyridin-3-yl)-1,3-thiazole-5-carboxylate; bacterial DNA gyrase or bacterial topoisomerase IV inhibitor; antibacterial agent; antibiotic resistance; skin structure infections, pneumoniae, bronchitis, acute sinusitis, otitis media, sepsis, osteomyelitis |
| 06/05/2008 | US20080132545 Certain chemical entities, compositions, and methods |
| 06/05/2008 | US20080132507 Hydrazide Derivatives |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/05/2008 | DE102006056208A1 Producing aromatic or heteroaromatic nitriles comprises reacting a (hetero)aryl halide or sulfonate with potassium ferro- or ferricyanide in the presence of a palladium compound and a phosphine |
| 06/04/2008 | EP1927604A1 Functional monomers for molecular recognition and catalysis |
| 06/04/2008 | EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 06/04/2008 | EP1926703A1 Novel carboxylic acid derivatives |
| 06/04/2008 | EP1363886B1 Process and catalyst for the preparation of acetylpyridines |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
| 06/04/2008 | EP1015413B1 Use of an ingenane compound for the manufacture of a medicament for the treatment of cancer |
| 06/04/2008 | CN101193985A Cyanine coloring matter and optical recording medium |
| 06/04/2008 | CN101193895A Process for producing tricyclic ketone |
| 06/04/2008 | CN101193855A Substituted aryl oximes |
| 06/04/2008 | CN101193853A Anthranilic acid derivatives |
| 06/04/2008 | CN101190858A Method for catalytic manufacture of aromatic or heteroaromatic nitriles |
| 06/04/2008 | CN100392002C Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 06/04/2008 | CN100391947C Biphenylcarboxamide compound |
| 06/04/2008 | CN100391930C 1, 3-propane diol derivatives as bioactive compounds |
| 06/04/2008 | CN100391338C Arthropodicidal anthranilamides |
| 06/03/2008 | US7381826 Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
| 06/03/2008 | US7381734 Serine protease inhibitors |
| 06/03/2008 | US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide |
| 06/03/2008 | US7381399 For use as radiopharmaceuticals; solid phase synthesis; G-protein-coupled receptors |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 05/29/2008 | WO2008064036A1 Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| 05/29/2008 | WO2008062276A2 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 05/29/2008 | WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/29/2008 | WO2008061900A1 Polymerisation of ethylene and alpha olefins with single site catalysts having an anionic scorpion-like ligand |
| 05/29/2008 | WO2008061795A2 N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 05/29/2008 | WO2008012440A3 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 05/29/2008 | US20080125595 Single step one pot process for making nicardipine hydrochloride from 3-nitro-benzaldehyde, methyl aminocrotonate, and N-benzyl-N-methylaminoethyl acetoacetate; aqueous, injectable isotonic solution of nicardipine hydrochloride, L-arginine, and a sugar alcohol |
| 05/29/2008 | US20080125468 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents |
| 05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/29/2008 | US20080124571 Obtaining long-life blue light emission with high luminous efficiency |
| 05/29/2008 | US20080124402 N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor Modulators |
| 05/29/2008 | CA2670418A1 N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers's |
| 05/29/2008 | CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/28/2008 | EP1925620A1 Polymerisation of ethylene and alpha olefins with single site catalysts having an anionic scorpion-like ligand |
| 05/28/2008 | EP1924575A1 Anthranilamides for controlling invertebrate pests |
| 05/28/2008 | EP1924558A1 An antimalarial baylis-hillman adducts and a process for the preparation thereof |
| 05/28/2008 | EP1924554A1 Sulphonamide derivatives |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1423379B1 Ortho-substituted aryl amides for controlling invertebrate pests |
| 05/28/2008 | EP1404668B1 Variolin derivatives and their use as antitumor agents |
| 05/28/2008 | CN101189221A AMPA receptor potentiators |
| 05/28/2008 | CN101186549A Method for preparing amino acid by reducing ketoxime acid ester |
| 05/28/2008 | CN100390235C Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 05/28/2008 | CN100390160C Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/28/2008 | CN100390147C Process for the production of heteroaromatic nitriles improved catalyst therefor and a process for the production of said improved catalyst |
| 05/28/2008 | CN100390143C Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 05/28/2008 | CN100390133C Organic electroluminescent devices |
| 05/27/2008 | US7378555 Method of synthesizing camptothecin-relating compounds |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378527 Process for the preparation of torsemide and related intermediates |
| 05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
| 05/27/2008 | US7378447 Muscarinic agonists |
| 05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/27/2008 | US7378375 Substituted pyridine herbicides |
| 05/27/2008 | US7378194 Materials useful as electrolytic solutes |
| 05/22/2008 | WO2008061236A2 Sulfoximines as kinase inhibitors |
| 05/22/2008 | WO2008059960A1 Method for producing quarter-pyridine derivative and intermediate of quarter-pyridine derivative |
| 05/22/2008 | WO2008059551A2 Process for the preparation of imatinib and intermediates thereof |
| 05/22/2008 | WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 05/22/2008 | WO2008059023A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/22/2008 | WO2008058644A1 Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide |
| 05/22/2008 | WO2008058537A1 Novel 2-amino-pyridine derivatives and their use as potassium channel modulators |
| 05/22/2008 | WO2008058536A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 05/22/2008 | WO2008058341A1 Inhibitors of kinase activity |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
| 05/22/2008 | US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119451 N-(2-aminophenyl)-4-(3-methylpyridin-2-yl)benzamide; histone deacetylase (HDAC) and angiogenesis inhibitor; antiproliferative agent; solid tumor cancers, lymphomas, myelomas, melanomas; antiinflammatory agent; arthritis, psoriasis, multiple sclerosis, asthma |
| 05/22/2008 | US20080116453 Transition metal complex and light-emitting device |
| 05/22/2008 | US20080115890 Methods and systems for using molecular-film adhesives |
| 05/22/2008 | CA2701959A1 Inhibitors of kinase activity |
| 05/22/2008 | CA2669860A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/22/2008 | CA2669704A1 Sulfoximines as kinase inhibitors |